These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8971437

  • 1. Effects of picotamide, an antiplatelet agent, on cardiovascular, events in 438 claudicant patients with diabetes: a retrospective analysis of the ADEP study.
    Milani M, Longoni A, Maderna M.
    Br J Clin Pharmacol; 1996 Dec; 42(6):782-5. PubMed ID: 8971437
    [Abstract] [Full Text] [Related]

  • 2. A review of picotamide in the reduction of cardiovascular events in diabetic patients.
    Celestini A, Violi F.
    Vasc Health Risk Manag; 2007 Dec; 3(1):93-8. PubMed ID: 17583179
    [Abstract] [Full Text] [Related]

  • 3. Effect of picotamide on the clinical progression of peripheral vascular disease. A double-blind placebo-controlled study. The ADEP Group.
    Balsano F, Violi F.
    Circulation; 1993 May; 87(5):1563-9. PubMed ID: 8491012
    [Abstract] [Full Text] [Related]

  • 4. Hemodynamic, hemorheologic, and hemocoagulative changes after treatment with picotamide in patients affected by peripheral arterial disease (PAD) of the lower limbs.
    Neirotti M, Molaschi M, Ponzetto M, Macchione C, Poli L, Bonino F, Fabris F.
    Angiology; 1994 Feb; 45(2):137-41. PubMed ID: 8129189
    [Abstract] [Full Text] [Related]

  • 5. [The clinico-instrumental evaluation of the efficacy of picotamide in treating chronic obstructive arteriopathies of the lower extremities].
    Canonico V, Ammaturo V, Guarini P, Tedeschi C, Nunziata G, Nappi A, Forgione L, Rengo F.
    Minerva Cardioangiol; 1991 Mar; 39(3):75-80. PubMed ID: 1881558
    [Abstract] [Full Text] [Related]

  • 6. Effects of picotamide, an antithromboxane agent, on carotid atherosclerotic evolution. A two-year, double-blind, placebo-controlled study in diabetic patients.
    Cocozza M, Picano T, Oliviero U, Russo N, Coto V, Milani M.
    Stroke; 1995 Apr; 26(4):597-601. PubMed ID: 7709404
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of picotamide in long-term treatment of intermittent claudication.
    Coto V, Cocozza M, Oliviero U, Lucariello A, Picano T, Coto F, Cacciatore L.
    Angiology; 1989 Oct; 40(10):880-5. PubMed ID: 2679241
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients.
    Giustina A, Perini P, Desenzani P, Bossoni S, Ianniello P, Milani M, Davì G, Romanelli G.
    Diabetes; 1998 Mar; 47(3):423-30. PubMed ID: 9519749
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiaggregatory effects of picotamide in long-term treatment: a 2-year, double-blind placebo-controlled trial.
    Cocozza M, Milani M, Picano T, Oliviero U, Russo N, Coto V.
    Vasc Med; 1997 Nov; 2(4):292-5. PubMed ID: 9575601
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical study of picotamide in patients with vascular diseases].
    Speziale F, Taurino M, Colella E, Rizzo L, Fiorani P.
    Recenti Prog Med; 1989 May; 80(5):271-5. PubMed ID: 2762664
    [Abstract] [Full Text] [Related]

  • 14. The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes.
    Neri Serneri GG, Gensini GF, Poggesi L, Modesti PA, Rostagno C, Boddi M, Gori AM, Martini F, Ieri A, Margheri M.
    Coron Artery Dis; 1994 Feb; 5(2):137-45. PubMed ID: 8180744
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Changes in morning platelet aggregation in patients with peripheral obliterating arteriopathy after evening administration of picotamide].
    Craveri A, Colombo L, Cristina M, Coloru M, De Angeli B, Lanfredini M.
    Clin Ter; 1991 Jan 15; 136(1):23-9. PubMed ID: 1826869
    [Abstract] [Full Text] [Related]

  • 17. Picotamide in migraine aura prevention: a pilot study.
    Allais G, D'Andrea G, Airola G, De Lorenzo C, Mana O, Benedetto C.
    Neurol Sci; 2004 Oct 15; 25 Suppl 3():S267-9. PubMed ID: 15549555
    [Abstract] [Full Text] [Related]

  • 18. [Picotamide: prevention and therapy of diabetic vasculopathies. A double-blind clinical study].
    Pibiri L, Petruzzo P, De Giudici A, Brotzu G.
    Clin Ter; 1990 May 31; 133(4):233-7. PubMed ID: 2142911
    [Abstract] [Full Text] [Related]

  • 19. Binding kinetics and antiplatelet activities of picotamide, a thromboxane A2 receptor antagonist.
    Modesti PA, Cecioni I, Colella A, Costoli A, Paniccia R, Neri Serneri GG.
    Br J Pharmacol; 1994 May 31; 112(1):81-6. PubMed ID: 8032666
    [Abstract] [Full Text] [Related]

  • 20. [Antiplatelet activity of picotamide in patients with chronic vascular pathology].
    Coto V, Carrieri P, Cocozza M, Oliviero U, Picano T, Spinoli G, Cacciatore L.
    Minerva Cardioangiol; 1986 Sep 31; 34(9):601-4. PubMed ID: 2949164
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.